DK0445460T3 - Mikroorganisme til selektiv fremstilling af en specifik bestanddel af avermectin og fremgangsmåde til fremstilling deraf - Google Patents

Mikroorganisme til selektiv fremstilling af en specifik bestanddel af avermectin og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0445460T3
DK0445460T3 DK90308842.5T DK90308842T DK0445460T3 DK 0445460 T3 DK0445460 T3 DK 0445460T3 DK 90308842 T DK90308842 T DK 90308842T DK 0445460 T3 DK0445460 T3 DK 0445460T3
Authority
DK
Denmark
Prior art keywords
avermectin
preparation
microorganism
acid
specific constituent
Prior art date
Application number
DK90308842.5T
Other languages
English (en)
Inventor
Satoshi Omura
Haruo Ikeda
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Application granted granted Critical
Publication of DK0445460T3 publication Critical patent/DK0445460T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C12N15/03—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK90308842.5T 1990-03-05 1990-08-10 Mikroorganisme til selektiv fremstilling af en specifik bestanddel af avermectin og fremgangsmåde til fremstilling deraf DK0445460T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2053411A JP2888586B2 (ja) 1990-03-05 1990-03-05 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法

Publications (1)

Publication Number Publication Date
DK0445460T3 true DK0445460T3 (da) 1995-08-14

Family

ID=12942087

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90308842.5T DK0445460T3 (da) 1990-03-05 1990-08-10 Mikroorganisme til selektiv fremstilling af en specifik bestanddel af avermectin og fremgangsmåde til fremstilling deraf

Country Status (10)

Country Link
US (2) US5206155A (da)
EP (1) EP0445460B1 (da)
JP (1) JP2888586B2 (da)
AT (1) ATE123805T1 (da)
AU (1) AU629966B2 (da)
CA (1) CA2023114C (da)
DE (1) DE69020138T2 (da)
DK (1) DK0445460T3 (da)
ES (1) ES2075881T3 (da)
NZ (1) NZ234741A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103504A (en) * 1992-03-25 2000-08-15 Pfizer Inc. Process for production of avermectins and cultures therefor
IT1255135B (it) * 1992-05-05 1995-10-20 Principio attivo a base di avermectine, ceppo e procedimento per la sua preparazione e composizione veterinaria che lo contiene.
US5292647A (en) * 1992-11-30 1994-03-08 Eli Lilly And Company Strain of streptomyces for producing avermectins and processes therewith
DE69415675T2 (de) * 1993-07-23 1999-05-20 Pfizer Verfahren zur Ausfällung von natürlichen Avermectinen, sowie Fermentationsverfahren zur Herstellung derselben
BR9907893A (pt) * 1998-02-13 2000-11-14 Pfizer Prod Inc Gene de streptomyces avermitilis que dirige a proporção de avermectinas b2:b1
US6605595B1 (en) 1999-02-09 2003-08-12 The Kitasato Institute Avermectin derivatives
JP2000245457A (ja) 1999-02-24 2000-09-12 Kitasato Inst:The エバーメクチンアグリコン合成酵素遺伝子
JPWO2002012261A1 (ja) 2000-08-09 2004-01-15 社団法人北里研究所 エバーメクチン誘導体
CA2418975C (en) 2000-08-09 2012-01-17 Satoshi Omura Avermectin derivatives
CN101429536B (zh) * 2008-12-15 2011-09-14 浙江升华拜克生物股份有限公司 一种采用全孢子接种工艺生产阿维菌素的方法
MX2016011367A (es) * 2014-03-10 2017-02-02 Zhejiang Hisun Pharm Co Ltd Microorganismo recombinante que expresa analogos de avermectina y uso de los mismos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (da) * 1987-01-23 1991-01-19 Pfizer
ES2054822T3 (es) * 1987-10-23 1994-08-16 Pfizer Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.

Also Published As

Publication number Publication date
JPH03254678A (ja) 1991-11-13
AU6020190A (en) 1991-09-05
AU629966B2 (en) 1992-10-15
ES2075881T3 (es) 1995-10-16
EP0445460B1 (en) 1995-06-14
EP0445460A1 (en) 1991-09-11
JP2888586B2 (ja) 1999-05-10
US5206155A (en) 1993-04-27
ATE123805T1 (de) 1995-06-15
CA2023114A1 (en) 1991-09-06
DE69020138T2 (de) 1995-12-14
US5369021A (en) 1994-11-29
NZ234741A (en) 1992-03-26
DE69020138D1 (de) 1995-07-20
CA2023114C (en) 1996-12-17

Similar Documents

Publication Publication Date Title
FI991477A (fi) Menetelmä tolterodiinin valmistamiseksi
AU7773891A (en) High-strength, thin-walled single piece catheters
EP0798285A3 (en) 3,4,4-Trifluoro-3-butenoic acid or its methyl ester
DK0445460T3 (da) Mikroorganisme til selektiv fremstilling af en specifik bestanddel af avermectin og fremgangsmåde til fremstilling deraf
PT98481A (pt) Processo para a preparacao de clatratos de peroxiacidos
FI891581A0 (fi) Peptidderivat.
YU108691A (sh) Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
FR2701580B1 (fr) Procédé d'administration d'applications avec des protocoles standards.
MD1788F2 (en) Erythromycin A 9-O-oximes derivatives, pharmaceutical composition on base thereof and method of treatment of infectious diseases
DZ1687A1 (fr) Procédé d'extraction par membrane.
MX9204520A (es) Proceso para la preparacion de natamicina por fermentacion (caso ch 2074).
BR9304843A (pt) Cultura biologicamente pura do microorganismo de streptomyces avermitilis, processo para produzir pelo menos um composto de avermectina e avermectina assim produzida, processo para produzir ivermectina e ivermectina assim produzida.
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
SE9200428D0 (sv) Nytt antitumoerantibiotikum
NO178235C (no) Fremgangsmåte for mikrobiologisk fremstilling av L-carnitin
FI913699A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 4'-epi-4'-aminoantrasykliinien valmistamiseksi sekä menetelmässä käytettävät välituotteet
AU4927190A (en) Derivatives of 3-(L-pyroglutamyl)-L-thiazolidine-4-carboxylic acid and their pharmacological properties
ES2045146T3 (es) Avermectinas etiladas.
DE69116057D1 (de) Mikrobische Herstellung des 13-beta-13-deoxy-22,23,-dihydroavermectin-Bla/B1b-Aglycons
EP0083019A3 (en) Process for optically active anthracycline glycosides, the novel 4-deoxy-aclacinomycins a and b and pharmaceutical preparations
BR9609310A (pt) Derivados de 1,3-OXA(TIA)ZINA
DK0416327T3 (da) Kemiske derivater af antibiotika LL-E19020alfa og -beta
SU1626642A1 (ru) 3-Алкил-4-метил-2,9-диоксо-3,8-диазабицикло[4,3,0]нона-1(6), 4-диенилийперхлораты, обладающие противовоспалительным действием
AU640514C (en) 1,2-dioxetane compounds as chemiluminescent lables for organic and biological molecules
RO99683B1 (ro) Solutie medicamentoasa de uz topic cu efect antiinflamator si antireumatic